|Articles|July 1, 2013
- Applied Clinical Trials-08-01-2013
- Volume 22
- Issue 8
Applied Clinical Trials Digital Edition - July/August 2013
Trial Design: Risk-based Approaches: Best Practices for Ensuring Clinical Data Quality Regulatory: Clinical Research SOPs Also in this issue: Transparency in Europe Fragmented Study Conduct Landscape Comprehensive Evidence Development
Advertisement
Articles in this issue
over 12 years ago
Looking Further Into Transparencyover 12 years ago
The Practical Implementation of Risk-Based Monitoringover 12 years ago
Guidance and Strategies for Spurring Development of New Therapiesover 12 years ago
RBM in Late Phaseover 12 years ago
Paperless Clinical Trial Optimization—Thinking Outside the Boxover 12 years ago
Controversy Grows Over How Best to Share Dataover 12 years ago
SOPs in Clinical Researchover 12 years ago
Comprehensive Evidence Development: Progress and Opportunitiesover 12 years ago
Risk-Based Approachesover 12 years ago
ACT Insert CoverNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
2
Proactive Planning is Key to Mitigating Study Rescue
3
ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results
4
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
